Avivagen Company Top Insiders
| VIVXF Stock | USD 0.0001 0.00 0.00% |
Avivagen employs about 13 people. The company is managed by 6 executives with a total tenure of roughly 31 years, averaging almost 5.0 years of service per executive, having 2.17 employees per reported executive. Examination of Avivagen's management performance can provide insight into the company performance.
| Tracy BVSC Insider Director Mang |
| Drew Basek Insider Director Relations |
Avivagen |
Avivagen Management Team Effectiveness
The company has return on total asset (ROA) of (0.9546) % which means that it has lost $0.9546 on every $100 spent on assets. This is way below average. Avivagen's management efficiency ratios could be used to measure how well Avivagen manages its routine affairs as well as how well it operates its assets and liabilities.Avivagen Workforce Comparison
Avivagen is rated third in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 55.0. Avivagen totals roughly 13.0 in number of employees claiming about 24% of equities under Drug Manufacturers—Specialty & Generic industry.
Avivagen Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Avivagen Price Series Summation is a cross summation of Avivagen price series and its benchmark/peer.
Avivagen Notable Stakeholders
An Avivagen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Avivagen often face trade-offs trying to please all of them. Avivagen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Avivagen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Tracy BVSC | Director Mang | Profile | |
| Drew Basek | Director Relations | Profile | |
| James Nickerson | Pres Innovation | Profile | |
| Graham Burton | Chief CoFounder | Profile | |
| Ira Levy | Interim Officer | Profile | |
| G Anthony | CEO Director | Profile |
About Avivagen Management Performance
The success or failure of an entity such as Avivagen often depends on how effective the management is. Avivagen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Avivagen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Avivagen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.
Avivagen Workforce Analysis
Traditionally, organizations such as Avivagen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Avivagen within its industry.Avivagen Manpower Efficiency
Return on Avivagen Manpower
| Revenue Per Employee | 99.7K | |
| Revenue Per Executive | 216K | |
| Net Loss Per Employee | 491.9K | |
| Net Loss Per Executive | 1.1M |
Complementary Tools for Avivagen Pink Sheet analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |